From the Chairman & Chief Executive Officer
Medicine should learn from every patient it treats.
Every family who walks into a neurology or psychiatry clinic is asked to accept something that would be unacceptable almost anywhere else in medicine: that finding the right treatment will take several attempts, that each will take weeks or months, and that no one can say in advance which will work.
My co-founder, Dr. Dilip Karnik, has spent more than forty years in pediatric neurology in Austin. He will tell you the hardest conversation in the clinic is not a difficult diagnosis. It is telling a parent that the first medication did not work, and that the next one is also, in the end, a considered guess.
I have spent three decades building data and AI systems, and four companies. When I turned to this problem I expected to find the science was not ready. That is not what I found.
The science has moved. We can read a patient’s genome, model their neurobiology, and rank therapies with real precision. The other half is missing. In the largest trial of genomic prescribing in depression, giving physicians a genetic report changed what they prescribed dramatically - and barely changed whether patients got better. The information helped at the moment of the decision. Nothing came back afterwards to say what happened.
That is the gap POD Health was founded to close.
Brain care is the one field of medicine where the answer arrives every day - in how a patient sleeps, moves, breathes and feels. We built a system to listen for it.
We built three things that work as one. NeuroPrecision Dx reads the patient’s pharmacogenomics. The NeuroTwin - a computed model of that individual’s neurobiology - uses it, with everything else we know about them, to rank treatments and explain its reasoning to the physician who has to sign. And Piper, in the hands of the patient and their family, follows what happens next: whether the medicine is taken, whether anxiety and depression lift, how the patient sleeps, and for our patients with epilepsy, their blood oxygen through the night.
That last part matters most, and it is the part almost no one builds. In cancer care the answer to “did this work” arrives on a scan months later. In brain care it arrives daily, in the patient’s own home - and today it is thrown away. We keep it, we learn from it, and every patient we care for makes the system better for the one who comes next.
We are equally deliberate about what we will not claim. POD Health does not diagnose, does not prescribe, and does not decide. Every recommendation is reviewed and signed by a treating physician. We are building the evidence with clinical and academic partners, and we will publish what we find - including the findings we did not hope for.
The winner in brain health will not be whoever holds the most data. It will be whoever learns fastest from every patient. That is the company we are building.
Mohammed Farooq
Founder, Chairman & Chief Executive Officer, POD Health